Sfoglia per AUTORE
LIU B
Collezione AOU San Luigi di Orbassano
Items : 2
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2024 Oct 20;42(30):3593-3605. doi: 10.1200/JCO.24.01001. Epub 2024 Jun 10.
2024
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Leighl NB; Akamatsu H; Lim SM; Cheng Y; Minchom AR; Marmarelis ME; Sanborn RE; Chih-Hsin Yang J; Liu B; John T; Massutí B; Spira AI; Lee SH; Wang J; Li J; Liu C; Novello S; Kondo M; Tamiya M; Korbenfeld E; Moskovitz M; Han JY; Alexander M; Joshi R; Felip E; Voon PJ; Danchaivijitr P; Hsu PC; Silva Melo Cruz FJ; et alii...
Rate and risk factors of recurrent immune checkpoint inhibitor-related pneumonitis in patients with lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Mar;11(3):381-392. doi: 10.21037/tlcr-22-168.
2022
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Tao H; Li F; Wu D; Ji S; Liu Q; Wang L; Liu B; Facchinetti F; Leong TL; Passiglia F; Hu Y;